Kemia-Kemi Vol. 40 (2013) 5

Carmela Kantor-Aaltonen

Introduction

In many ways, the biotech sector in Finland has had a remarkable 2013. It has been a year of enforcement of the biobank law, trading licenses for Finnish drugs, and new strategies for the health care sector and bioeconomy.

Download article PDF